KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $2.30 $3.29 Friday, 26th Apr 2024 ABUS stock ended at $2.73. This is 0.368% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 2.21% from a day low at $2.71 to a day high of $2.77.
90 days $2.27 $3.29
52 weeks $1.69 $3.29

Historical Arbutus Biopharma Corporation prices

Date Open High Low Close Volume
Sep 25, 2020 $2.93 $3.14 $2.93 $3.08 1 070 094
Sep 24, 2020 $2.89 $2.98 $2.85 $2.92 1 910 496
Sep 23, 2020 $3.01 $3.05 $2.87 $2.94 1 474 274
Sep 22, 2020 $3.03 $3.07 $2.90 $3.03 1 207 449
Sep 21, 2020 $3.09 $3.10 $2.91 $3.03 1 987 613
Sep 18, 2020 $2.99 $3.19 $2.97 $3.14 3 719 207
Sep 17, 2020 $2.95 $3.07 $2.90 $2.98 2 322 837
Sep 16, 2020 $2.90 $2.99 $2.78 $2.90 2 534 932
Sep 15, 2020 $2.98 $3.39 $2.81 $2.94 13 215 701
Sep 14, 2020 $2.35 $2.67 $2.35 $2.62 1 516 066
Sep 11, 2020 $2.42 $2.49 $2.36 $2.37 850 973
Sep 10, 2020 $2.60 $2.61 $2.39 $2.41 1 302 371
Sep 09, 2020 $2.53 $2.68 $2.47 $2.54 1 194 600
Sep 08, 2020 $2.38 $2.54 $2.31 $2.47 1 463 085
Sep 04, 2020 $2.49 $2.54 $2.33 $2.44 2 021 599
Sep 03, 2020 $2.65 $2.74 $2.53 $2.54 1 669 149
Sep 02, 2020 $2.71 $2.74 $2.57 $2.65 1 455 747
Sep 01, 2020 $2.90 $2.90 $2.68 $2.76 2 086 216
Aug 31, 2020 $2.94 $2.95 $2.85 $2.91 1 782 950
Aug 28, 2020 $2.93 $3.05 $2.88 $3.03 1 761 555
Aug 27, 2020 $2.90 $2.95 $2.83 $2.92 2 249 889
Aug 26, 2020 $3.03 $3.11 $2.92 $2.93 2 821 695
Aug 25, 2020 $3.01 $3.14 $2.92 $3.00 2 256 631
Aug 24, 2020 $3.18 $3.24 $3.01 $3.01 2 538 156
Aug 21, 2020 $3.33 $3.44 $3.16 $3.18 2 392 595
Click to get the best stock tips daily for free!

About Arbutus Biopharma Corporation

Arbutus Biopharma Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel ... ABUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT